Reckitt Benckiser Group (LON:RKT) Receives Buy Rating from Deutsche Bank Aktiengesellschaft

Reckitt Benckiser Group (LON:RKTGet Rating)‘s stock had its “buy” rating reissued by equities research analysts at Deutsche Bank Aktiengesellschaft in a report released on Thursday, MarketBeat.com reports. They presently have a GBX 7,200 ($90.60) price objective on the stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 16.13% from the stock’s current price.

A number of other research firms have also commented on RKT. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Reckitt Benckiser Group in a report on Thursday, May 12th. Royal Bank of Canada upgraded shares of Reckitt Benckiser Group to an “outperform” rating and upped their price target for the company from GBX 5,900 ($74.24) to GBX 7,000 ($88.08) in a report on Wednesday, May 18th. Berenberg Bank boosted their price objective on shares of Reckitt Benckiser Group from GBX 7,460 ($93.87) to GBX 7,700 ($96.89) and gave the company a “buy” rating in a research report on Friday, April 29th. Morgan Stanley reissued an “overweight” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, May 11th. Finally, Barclays reissued an “overweight” rating and set a GBX 9,300 ($117.03) price objective on shares of Reckitt Benckiser Group in a research report on Friday, May 20th. Nine research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Reckitt Benckiser Group has an average rating of “Buy” and a consensus target price of GBX 7,677.78 ($96.61).

LON:RKT opened at GBX 6,200 ($78.02) on Thursday. The company has a fifty day moving average of GBX 6,068.74 and a 200 day moving average of GBX 6,115.14. Reckitt Benckiser Group has a 52 week low of GBX 4,905.16 ($61.72) and a 52 week high of GBX 6,709 ($84.42). The company has a quick ratio of 0.40, a current ratio of 0.62 and a debt-to-equity ratio of 129.26. The firm has a market capitalization of £44.32 billion and a P/E ratio of -1,378.41.

In other news, insider Laxman Narasimhan sold 7,713 shares of the company’s stock in a transaction dated Friday, May 20th. The shares were sold at an average price of GBX 6,214 ($78.19), for a total value of £479,285.82 ($603,102.83).

Reckitt Benckiser Group Company Profile (Get Rating)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading

Analyst Recommendations for Reckitt Benckiser Group (LON:RKT)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.